Journal Retracts Studies Cited in Federal Court Ruling Against Abortion Pillnews2024-02-09T23:07:08+00:00February 9th, 2024|The New York Times|
Years After Monsanto Deal, Bayer’s Roundup Bills Keep Piling Upnews2023-12-06T11:59:57+00:00December 6th, 2023|The New York Times|
Rite Aid Files for Bankruptcy, Facing Slumping Sales and Opioid Suitsnews2023-10-16T06:05:18+00:00October 16th, 2023|The New York Times|
Drug Makers Agree to Negotiate With Medicare on Prices of 10 Medicationsnews2023-10-03T22:38:52+00:00October 3rd, 2023|The New York Times|
Supporters of Aid in Dying Sue N.J. Over Residency Requirementnews2023-09-16T09:02:08+00:00September 16th, 2023|The New York Times|
Justice Dept. Asks Supreme Court to Hear Abortion Pill Casenews2023-09-08T23:06:10+00:00September 8th, 2023|The New York Times|
Mallinckrodt’s Bankruptcy Plan Would Cut Payments to Opioid Victims by $1 Billionnews2023-08-23T20:33:07+00:00August 23rd, 2023|The New York Times|
Opioid Settlement Money Is Being Spent on Police Cars and Overtimenews2023-08-15T00:03:26+00:00August 15th, 2023|The New York Times|
Drugmakers Throw ‘Kitchen Sink’ to Halt Medicare Price Negotiationsnews2023-07-23T07:00:18+00:00July 23rd, 2023|The New York Times|
How Gilead Profited by Slow-Walking a Promising H.I.V. Therapynews2023-07-22T18:26:55+00:00July 22nd, 2023|The New York Times|
